Latest News
The ocean waters have gotten wavy this year, but there's opportunity in the volatility for these three cruise-related investments.
Via The Motley Fool · April 11, 2025
Via The Motley Fool · April 11, 2025
Opportunistic investors are buying Symbotic stock after its steep fall.
Via The Motley Fool · April 11, 2025
Revenue rose 17% year-over-year to $17.74 billion during the quarter, surpassing a Wall Street estimate of $16.55 billion. Earnings per share stood at $2.6 versus an estimated $2.21.
Via Stocktwits · April 11, 2025
Via The Motley Fool · April 11, 2025
After opening higher, Indian benchmark indices rallied as the session progressed, ending the day strongly.
Via Talk Markets · April 11, 2025
Richtech Robotics (NASDAQ: RR) offers attractive opportunity to invest in rising demand for service robotics, according to analyst Scott Buck. Buy rating and $3.50 price target. RaaS model and improving financial performance make it a strong buy.
Via Benzinga · April 11, 2025
Insights on real estate tokenization, its growing relevance today, and key factors which investors should watch.
Via Benzinga · April 11, 2025
Via The Motley Fool · April 11, 2025
Google reached a deal with GSA to lower federal government costs for its products and services, including a temporary 71% discount for Workspace until 2025. It also expanded pricing for its GCP services and added AI features.
Via Benzinga · April 11, 2025
Treasury yields kept surging on Friday as the dollar sells off. It's not normal.
Via Investor's Business Daily · April 11, 2025
Via Benzinga · April 11, 2025
The stock market had its best day in years amid a wild week on a Trump tariff pause. JPMorgan, Delta and others warned on tariff impacts.
Via Investor's Business Daily · April 11, 2025
Shares of Wells Fargo (WFC) are trading at a support level. There is a good chance that they begin to trend higher.
Via Benzinga · April 11, 2025
JPMorgan, which holds a ‘Neutral’ rating on the stock, opined that Charles River could see disruption from customers reassessing its preclinical strategies in the near term.
Via Stocktwits · April 11, 2025
Via Benzinga · April 11, 2025
Via Benzinga · April 11, 2025
Via Benzinga · April 11, 2025
Via Benzinga · April 11, 2025
Via Benzinga · April 11, 2025